+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
All Genders
ID07777835

Evaluating Magnesium Sulphate Plus Standard Therapy Compared to Standard Therapy Alone for Acute Organophosphate Poisoning

Led by Muhammad Aamir Latif · Updated on 2026-08-20

38

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Organophosphate poisoning is a serious health issue in regions like Pakistan, where it is common and challenging to manage. This trial evaluates magnesium sulphate as an additional treatment alongside the standard atropine and pralidoxime therapy. The goal is to compare the 15-day mortality rates and the total atropine needed during hospital stays between patients receiving the combined treatment and those receiving standard care alone. The study also aims to understand whether adding magnesium sulphate can better manage complications such as Intermediate Syndrome and reduce the need for ventilators. Participants will be randomly assigned to one of two groups. One group will receive the standard atropine and pralidoxime therapy plus adjunctive magnesium sulphate, which involves an initial loading dose followed by continuous intravenous infusion over 24 hours. The other group will receive only the standard atropine and pralidoxime treatment without magnesium sulphate. This approach allows researchers to assess the potential benefits and impacts of magnesium sulphate as part of the treatment regimen. Throughout the study, participants will be monitored for mortality within 15 days after hospital admission, the occurrence of Intermediate Syndrome within 7 days, and atropine consumption. Researchers will also observe the need for mechanical ventilation, respiratory failure, and length of hospital stay. The study starts with screening and informed consent, followed by treatment and observation during hospitalization. The total participation duration aligns with the critical treatment and monitoring period of up to 15 days post-admission.

CONDITIONS

Brief Title

Magnesium Sulphate With Atropine and Pralidoxime vs Standard Therapy Alone in Acute Organophosphate Poisoning

Research Team

S

Sana Usman

A

Arif Mahmood, FCPS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here